Who invested in Pliant Therapeutics?
Pliant Therapeutics's investors include Menlo Ventures, Cormorant Asset Management, Redmile Group, Schroder Adveq and Agent, and 2 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$350Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $62M sold, first sale Jul 2018
From Pliant Therapeutics's own website and the SEC filings it signed: 14 on the team.
On the board, as filediCharles HomcyHoyoung HuhJohn CurnutteKevin RaidyNeil ExterSmital ShahSuzanne Bruhn
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Pliant Therapeutics's investors include Menlo Ventures, Cormorant Asset Management, Redmile Group, Schroder Adveq and Agent, and 2 more on record.
Pliant Therapeutics has raised $350M across 2 rounds since 2018.
Pliant Therapeutics's most recent round was an Undisclosed round of $288M in Jan 2023.
Its most recent round, $288M in Jan 2023, is also its largest on record.
Pliant Therapeutics's first round on record, in Jul 2018, was backed by Menlo Ventures, Schroder Adveq and Agent and 2 others.
Pliant Therapeutics's latest named round is an Undisclosed round, in Jan 2023.
Pliant Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.